KR20010053254A - 무스카린성 길항제 - Google Patents
무스카린성 길항제 Download PDFInfo
- Publication number
- KR20010053254A KR20010053254A KR1020007014935A KR20007014935A KR20010053254A KR 20010053254 A KR20010053254 A KR 20010053254A KR 1020007014935 A KR1020007014935 A KR 1020007014935A KR 20007014935 A KR20007014935 A KR 20007014935A KR 20010053254 A KR20010053254 A KR 20010053254A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- alkyl
- hydrogen
- etoac
- added
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10798398A | 1998-06-30 | 1998-06-30 | |
| US09/107,983 | 1998-06-30 | ||
| PCT/US1999/012821 WO2000000488A1 (en) | 1998-06-30 | 1999-06-28 | Muscarinic antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010053254A true KR20010053254A (ko) | 2001-06-25 |
Family
ID=22319562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007014935A KR20010053254A (ko) | 1998-06-30 | 1999-06-28 | 무스카린성 길항제 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1091956B1 (de) |
| JP (1) | JP3344997B2 (de) |
| KR (1) | KR20010053254A (de) |
| CN (1) | CN1146559C (de) |
| AR (1) | AR019167A1 (de) |
| AT (1) | ATE272632T1 (de) |
| AU (1) | AU756484B2 (de) |
| CA (1) | CA2336000C (de) |
| DE (1) | DE69919171T2 (de) |
| ES (1) | ES2221399T3 (de) |
| HU (1) | HUP0104058A2 (de) |
| IL (1) | IL140249A0 (de) |
| MY (1) | MY133108A (de) |
| NZ (1) | NZ508910A (de) |
| TW (1) | TW474933B (de) |
| WO (1) | WO2000000488A1 (de) |
| ZA (1) | ZA200007555B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2299206C9 (ru) * | 1999-05-04 | 2007-11-20 | Шеринг Корпорейшн | Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5 |
| US6391865B1 (en) | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| US6635646B1 (en) | 1999-05-04 | 2003-10-21 | Schering Corporation | Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| US6689765B2 (en) | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| US6294554B1 (en) | 1999-09-22 | 2001-09-25 | Schering Corporation | Muscarinic antagonists |
| ATE264301T1 (de) * | 1999-09-22 | 2004-04-15 | Schering Corp | Muscarin-antagonisten |
| AR033517A1 (es) | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| MXPA03008356A (es) | 2001-03-13 | 2003-12-11 | Schering Corp | Compuestos del tipo no imidazol como antagonistas de histamina h3. |
| RU2004100839A (ru) | 2001-07-02 | 2005-06-20 | Астразенека Аб (Se) | Производные пиперидина полезные в качестве модуляторов активности рецепторов хемокинов |
| GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
| GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0202838D0 (sv) * | 2002-09-24 | 2002-09-24 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
| US20080200505A1 (en) * | 2005-05-27 | 2008-08-21 | Astrazeneca Ab | Piperidines for the Treatment of Chemokine Mediated Diseases |
| US8314127B2 (en) | 2005-07-21 | 2012-11-20 | Astrazeneca Ab | Piperidine derivatives |
| JP5550352B2 (ja) * | 2007-03-15 | 2014-07-16 | ノバルティス アーゲー | 有機化合物およびその使用 |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| CN104356056B (zh) * | 2014-11-19 | 2017-04-05 | 南京华威医药科技开发有限公司 | 吡仑帕奈中间体的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
-
1999
- 1999-06-28 DE DE69919171T patent/DE69919171T2/de not_active Expired - Lifetime
- 1999-06-28 JP JP2000557249A patent/JP3344997B2/ja not_active Expired - Fee Related
- 1999-06-28 ES ES99931768T patent/ES2221399T3/es not_active Expired - Lifetime
- 1999-06-28 AT AT99931768T patent/ATE272632T1/de not_active IP Right Cessation
- 1999-06-28 CA CA002336000A patent/CA2336000C/en not_active Expired - Fee Related
- 1999-06-28 KR KR1020007014935A patent/KR20010053254A/ko not_active Application Discontinuation
- 1999-06-28 WO PCT/US1999/012821 patent/WO2000000488A1/en active IP Right Grant
- 1999-06-28 AR ARP990103104A patent/AR019167A1/es unknown
- 1999-06-28 CN CNB998100765A patent/CN1146559C/zh not_active Expired - Fee Related
- 1999-06-28 MY MYPI99002663A patent/MY133108A/en unknown
- 1999-06-28 NZ NZ508910A patent/NZ508910A/xx unknown
- 1999-06-28 TW TW088110871A patent/TW474933B/zh not_active IP Right Cessation
- 1999-06-28 IL IL14024999A patent/IL140249A0/xx unknown
- 1999-06-28 EP EP99931768A patent/EP1091956B1/de not_active Expired - Lifetime
- 1999-06-28 AU AU48201/99A patent/AU756484B2/en not_active Ceased
- 1999-06-28 HU HU0104058A patent/HUP0104058A2/hu unknown
-
2000
- 2000-12-15 ZA ZA200007555A patent/ZA200007555B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ508910A (en) | 2003-01-31 |
| CN1314905A (zh) | 2001-09-26 |
| EP1091956B1 (de) | 2004-08-04 |
| DE69919171T2 (de) | 2005-08-04 |
| AR019167A1 (es) | 2001-12-26 |
| HUP0104058A2 (hu) | 2002-03-28 |
| CN1146559C (zh) | 2004-04-21 |
| TW474933B (en) | 2002-02-01 |
| WO2000000488A1 (en) | 2000-01-06 |
| JP3344997B2 (ja) | 2002-11-18 |
| ES2221399T3 (es) | 2004-12-16 |
| CA2336000C (en) | 2006-10-10 |
| CA2336000A1 (en) | 2000-01-06 |
| AU4820199A (en) | 2000-01-17 |
| ZA200007555B (en) | 2002-03-15 |
| AU756484B2 (en) | 2003-01-16 |
| JP2002519349A (ja) | 2002-07-02 |
| DE69919171D1 (de) | 2004-09-09 |
| ATE272632T1 (de) | 2004-08-15 |
| IL140249A0 (en) | 2002-02-10 |
| MY133108A (en) | 2007-10-31 |
| EP1091956A1 (de) | 2001-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6451797B1 (en) | Muscarinic antagonists | |
| KR20010053254A (ko) | 무스카린성 길항제 | |
| US6498168B2 (en) | Muscarinic antagonists | |
| KR101697518B1 (ko) | 히스톤 탈아세틸화효소 6 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물 | |
| AU2007304475B2 (en) | Substituted sulfonamide derivatives | |
| EP2566859B1 (de) | Picolinamid- und pyrimidin-4-carboxamid-verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung damit | |
| KR100344332B1 (ko) | 피페라진 유도체 및 이를 함유하는 약제학적 조성물 | |
| JP5237324B2 (ja) | セロトニン様作用薬としてのインダゾールアミド化合物 | |
| AU2004281214B2 (en) | Derivatives of N-``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics | |
| SK17222002A3 (sk) | Inhibítory serínových proteáz | |
| EP1260512A1 (de) | Zyklische amid-derivate | |
| EP3526203B1 (de) | N-aryl- und n-heteroaryl-piperidin-derivate als leber-x-rezeptor-beta-agonisten, zusammensetzungen und deren verwendung | |
| KR20060095865A (ko) | 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체 | |
| SK280812B6 (sk) | 1,3-substituované cykloalkány a 1,3-substituované cykloalkény, spôsoby ich prípravy a farmaceutické prípravky na ich báze | |
| SK6112003A3 (en) | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders | |
| SK141998A3 (en) | Piperidines and pyrrolidines | |
| IE862636L (en) | Diphenyl piperidines | |
| JP2006501246A (ja) | 神経変性疾患の治療において有用なアナバセイン誘導体 | |
| EP2733144A1 (de) | Neue verbindung mit parp-hemmender wirkung | |
| NZ243337A (en) | 1-piperidyl substituted quinoline derivatives and pharmaceutical compositions | |
| US6680329B2 (en) | N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants | |
| US4826843A (en) | Cerebral function enhancing diazinylpiperidine derivatives | |
| CA2038417A1 (en) | Piperidine compounds, method for preparation thereof, and a pharmaceutical composition comprising the same | |
| CN117586179A (zh) | 一种gpr183拮抗剂及其合成方法和应用 | |
| MXPA01000106A (es) | Antagonistas muscarinicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |